SCHEMBL29960410

SCHEMBL29960410

CCOC(=O)C1CN(C(=O)OC(C)(C)C)CCC1c1ccccc1OC

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 6/20 0.47
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
PDE4A P27815 2/20 0.44
PDE4C Q08493 2/20 0.44
PDE4D Q08499 2/20 0.44
TACR1 P25103 1/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
HPGD P15428 1/20 0.42
GPR119 Q8TDV5 2/20 0.41
ATM Q13315 1/20 0.41
TGFBR1 P36897 1/20 0.41
TP53 P04637 1/20 0.41
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31449856 0.87 TSHR (0.45) ALDH1A1KDM4EGAATACR1MEN1
SCHEMBL23982323 0.86 PDE4B (0.52) PDE4BALDH1A1KDM4ETACR1MEN1
SCHEMBL12647197 0.84 TACR1 (0.58) TACR1GPR119
SCHEMBL4790687 0.84 TACR1 (0.58) TACR1GPR119
SCHEMBL2240106 0.84 TACR1 (0.58) TACR1GPR119
SCHEMBL14934668 0.82 ALDH1A1 (0.50) PDE4BALDH1A1KDM4EGAAPDE4A
SCHEMBL18586188 0.82 ALDH1A1 (0.50) PDE4BALDH1A1KDM4EGAAPDE4A
SCHEMBL16141380 0.82 ALDH1A1 (0.50) PDE4BALDH1A1KDM4EGAAPDE4A
SCHEMBL14920417 0.82 ALDH1A1 (0.50) PDE4BALDH1A1KDM4EGAAPDE4A
SCHEMBL14920416 0.82 ALDH1A1 (0.50) PDE4BALDH1A1KDM4EGAAPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed